Skip to main content

J.P. Morgan Sticks to Its Buy Rating for Perrigo Company (PRGO)

Tipranks - Fri Aug 8, 2025

J.P. Morgan analyst Chris Schott maintained a Buy rating on Perrigo Company today and set a price target of $35.00. The company’s shares opened today at $23.75.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Schott covers the Healthcare sector, focusing on stocks such as Teva Pharmaceutical, Merck & Company, and Pfizer. According to TipRanks, Schott has an average return of 0.9% and a 49.22% success rate on recommended stocks.

In addition to J.P. Morgan, Perrigo Company also received a Buy from Canaccord Genuity’s Susan Anderson in a report issued today. However, on the same day, TR | OpenAI – 4o reiterated a Hold rating on Perrigo Company (NYSE: PRGO).

PRGO market cap is currently $3.66B and has a P/E ratio of -42.26.

Based on the recent corporate insider activity of 29 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of PRGO in relation to earlier this year. Most recently, in May 2025, Geoffrey Parker, a Director at PRGO bought 3,500.00 shares for a total of $94,850.00.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.